Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,109.29
34.57
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,454.61
0.18%
3.46

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.08
4.85
4.80

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.76
6.04
7.24

PAT CAGR (%)

10 Years
5 Years
3 Years

12.23
7.34
11.65

P:E (Median)

8 Years
5 Years
3 Years

28.33
27.26
24.01

P:BV (Average)

8 Years
5 Years
3 Years

4.10
3.65
2.55

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.57
20.72
16.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 179.70 197.93 -9.21% 171.30 216.93 -21.03% 262.68 236.53 11.06% 216.64 154.56 40.17%
Expenses 142.35 148.66 -4.24% 140.61 139.60 0.72% 181.30 161.22 12.46% 139.05 111.59 24.61%
EBITDA 37.35 49.28 -24.21% 30.69 77.33 -60.31% 81.38 75.31 8.06% 77.59 42.98 80.53%
EBIDTM 20.78% 24.90% 17.92% 35.65% 30.98% 31.84% 35.81% 27.80%
Other Income 15.14 2.97 409.76% 8.61 2.43 254.32% 7.52 2.43 209.47% 2.64 3.43 -23.03%
Interest 6.64 1.29 414.73% 3.95 1.09 262.39% 3.34 0.63 430.16% 3.54 1.32 168.18%
Depreciation 10.62 9.16 15.94% 10.48 8.62 21.58% 9.84 8.61 14.29% 9.91 8.57 15.64%
PBT 35.23 37.26 -5.45% 24.87 70.04 -64.49% 75.72 68.50 10.54% 119.72 36.52 227.82%
Tax 8.63 11.89 -27.42% 7.99 12.78 -37.48% 20.95 12.94 61.90% 33.58 7.28 361.26%
PAT 26.59 25.36 4.85% 16.88 57.27 -70.53% 54.78 55.56 -1.40% 86.14 29.24 194.60%
PATM 14.80% 12.81% 9.85% 26.40% 20.85% 23.49% 39.76% 18.92%
EPS 3.26 3.11 4.82% 2.07 7.03 -70.55% 6.72 6.82 -1.47% 10.57 3.59 194.43%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 208.03 219.99 -5.44% 191.25 236.85 -19.25% 278.94 289.92 -3.79% 222.87 160.99 38.44%
Expenses 181.82 174.40 4.25% 170.28 163.11 4.40% 210.25 221.91 -5.25% 157.11 132.19 18.85%
EBITDA 26.21 45.60 -42.52% 20.97 73.74 -71.56% 68.68 68.00 1.00% 65.75 28.80 128.30%
EBIDTM 12.60% 20.73% 10.96% 31.13% 24.62% 23.46% 29.50% 17.89%
Other Income 6.91 8.91 -22.45% 8.61 3.25 164.92% 9.20 5.82 58.08% 5.48 1.98 176.77%
Interest 9.12 1.01 802.97% 4.80 1.27 277.95% 3.95 0.82 381.71% 4.00 1.46 173.97%
Depreciation 15.23 11.55 31.86% 13.72 10.97 25.07% 12.70 10.66 19.14% 12.33 10.66 15.67%
PBT 8.76 41.95 -79.12% 11.05 64.76 -82.94% 61.23 62.34 -1.78% 115.74 18.66 520.26%
Tax 0.80 7.55 -89.40% 2.92 10.53 -72.27% 15.99 11.18 43.02% 29.14 4.05 619.51%
PAT 7.97 34.40 -76.83% 8.14 54.24 -84.99% 45.24 51.16 -11.57% 86.60 14.61 492.74%
PATM 3.83% 15.64% 4.25% 22.90% 16.22% 17.65% 38.86% 9.07%
EPS 0.96 4.24 -77.36% 0.94 6.75 -86.07% 5.57 6.23 -10.59% 10.59 1.93 448.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 830.32 805.97 663.88 741.29 733.67 675.79 565.40 527.37 328.20 279.76 257.54 Net Sales Growth 3.02% 21.40% -10.44% 1.04% 8.56% 19.52% 7.21% 60.69% 17.31% 8.63% Cost Of Goods Sold 256.60 258.38 229.62 348.45 365.75 359.49 309.52 305.03 205.00 174.56 153.87 Gross Profit 573.72 547.60 434.26 392.85 367.92 316.30 255.88 222.34 123.19 105.20 103.67 GP Margin 69.10% 67.94% 65.41% 53.00% 50.15% 46.80% 45.26% 42.16% 37.54% 37.60% 40.25% Total Expenditure 603.31 568.18 494.86 573.43 560.97 511.35 431.01 409.65 262.79 223.47 188.15 Power & Fuel Cost - 35.31 31.39 27.00 24.56 20.54 17.58 15.55 8.83 7.63 5.65 % Of Sales - 4.38% 4.73% 3.64% 3.35% 3.04% 3.11% 2.95% 2.69% 2.73% 2.19% Employee Cost - 149.28 124.66 113.29 91.53 67.27 56.49 42.13 22.76 16.94 12.85 % Of Sales - 18.52% 18.78% 15.28% 12.48% 9.95% 9.99% 7.99% 6.93% 6.06% 4.99% Manufacturing Exp. - 75.34 55.63 55.48 50.58 42.10 29.78 22.80 13.28 10.20 7.83 % Of Sales - 9.35% 8.38% 7.48% 6.89% 6.23% 5.27% 4.32% 4.05% 3.65% 3.04% General & Admin Exp. - 24.76 16.55 12.15 11.52 9.00 6.57 6.41 7.67 6.45 4.02 % Of Sales - 3.07% 2.49% 1.64% 1.57% 1.33% 1.16% 1.22% 2.34% 2.31% 1.56% Selling & Distn. Exp. - 10.04 6.51 6.00 4.51 7.24 5.83 7.22 4.11 3.03 2.84 % Of Sales - 1.25% 0.98% 0.81% 0.61% 1.07% 1.03% 1.37% 1.25% 1.08% 1.10% Miscellaneous Exp. - 15.07 30.50 11.06 12.52 5.71 5.25 10.51 1.12 4.67 2.84 % Of Sales - 1.87% 4.59% 1.49% 1.71% 0.84% 0.93% 1.99% 0.34% 1.67% 0.42% EBITDA 227.01 237.79 169.02 167.86 172.70 164.44 134.39 117.72 65.41 56.29 69.39 EBITDA Margin 27.34% 29.50% 25.46% 22.64% 23.54% 24.33% 23.77% 22.32% 19.93% 20.12% 26.94% Other Income 33.91 40.02 17.16 34.52 29.82 11.14 7.51 8.85 5.01 7.79 9.10 Interest 17.47 4.33 2.79 2.12 2.79 3.27 3.88 3.40 1.95 1.97 2.27 Depreciation 40.85 34.96 34.01 32.78 26.66 21.19 19.09 21.09 12.75 11.44 10.42 PBT 255.54 238.53 149.38 167.49 173.08 151.12 118.93 102.08 55.72 50.66 65.79 Tax 71.15 40.27 31.49 34.25 41.09 35.84 34.84 21.23 9.65 11.54 14.91 Tax Rate 27.84% 17.21% 20.24% 20.45% 24.38% 24.10% 29.29% 20.80% 17.35% 22.50% 22.66% PAT 184.39 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 PAT before Minority Interest 184.39 193.72 124.11 133.24 127.45 112.86 84.10 80.86 45.96 39.75 50.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.21% 24.04% 18.69% 17.97% 17.37% 16.70% 14.87% 15.33% 14.00% 14.21% 19.76% PAT Growth 10.13% 56.09% -6.85% 4.54% 12.93% 34.20% 4.01% 75.94% 15.62% -21.88% EPS 22.62 23.77 15.23 16.35 15.64 13.85 10.32 9.92 5.64 4.88 6.24

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 901.09 907.91 733.39 788.83 779.16 716.43 613.80 571.38 371.32 318.18 290.29 Net Sales Growth -0.73% 23.80% -7.03% 1.24% 8.76% 16.72% 7.42% 53.88% 16.70% 9.61% Cost Of Goods Sold 270.75 277.73 257.03 355.87 371.81 366.19 323.16 313.26 213.95 183.22 162.98 Gross Profit 630.34 630.18 476.36 432.95 407.36 350.25 290.63 258.12 157.38 134.96 127.31 GP Margin 69.95% 69.41% 64.95% 54.89% 52.28% 48.89% 47.35% 45.17% 42.38% 42.42% 43.86% Total Expenditure 719.46 693.39 579.39 637.60 617.55 556.44 487.38 455.40 301.63 257.08 219.70 Power & Fuel Cost - 38.76 33.57 28.86 26.30 21.90 19.29 17.37 10.67 9.38 7.03 % Of Sales - 4.27% 4.58% 3.66% 3.38% 3.06% 3.14% 3.04% 2.87% 2.95% 2.42% Employee Cost - 196.59 176.40 149.35 127.87 90.09 82.30 67.83 42.56 33.68 28.37 % Of Sales - 21.65% 24.05% 18.93% 16.41% 12.57% 13.41% 11.87% 11.46% 10.59% 9.77% Manufacturing Exp. - 79.19 61.23 59.96 52.55 45.35 36.55 27.44 16.92 12.89 8.35 % Of Sales - 8.72% 8.35% 7.60% 6.74% 6.33% 5.95% 4.80% 4.56% 4.05% 2.88% General & Admin Exp. - 70.26 27.20 22.50 16.95 14.11 10.64 9.53 9.51 7.87 5.64 % Of Sales - 7.74% 3.71% 2.85% 2.18% 1.97% 1.73% 1.67% 2.56% 2.47% 1.94% Selling & Distn. Exp. - 10.40 6.72 6.37 4.75 7.27 5.99 7.29 4.43 3.19 4.63 % Of Sales - 1.15% 0.92% 0.81% 0.61% 1.01% 0.98% 1.28% 1.19% 1.00% 1.59% Miscellaneous Exp. - 20.47 17.23 14.68 17.32 11.54 9.45 12.68 3.59 6.86 4.63 % Of Sales - 2.25% 2.35% 1.86% 2.22% 1.61% 1.54% 2.22% 0.97% 2.16% 0.93% EBITDA 181.61 214.52 154.00 151.23 161.61 159.99 126.42 115.98 69.69 61.10 70.59 EBITDA Margin 20.15% 23.63% 21.00% 19.17% 20.74% 22.33% 20.60% 20.30% 18.77% 19.20% 24.32% Other Income 30.20 22.22 15.56 32.62 29.34 11.36 6.93 9.12 5.01 8.28 8.95 Interest 21.87 4.56 3.68 2.66 3.13 3.93 4.05 3.52 2.27 2.31 2.63 Depreciation 53.98 43.78 42.06 37.22 30.64 23.14 21.41 23.22 15.34 14.36 12.96 PBT 196.78 188.40 123.82 143.96 157.17 144.28 107.89 98.35 57.10 52.71 63.95 Tax 48.85 33.49 26.18 33.91 42.04 35.62 35.22 20.30 9.53 12.22 14.60 Tax Rate 24.82% 17.78% 18.22% 23.56% 27.54% 25.11% 32.66% 21.27% 16.72% 22.91% 22.83% PAT 147.95 156.50 120.28 112.43 113.71 109.84 73.69 75.67 47.35 41.23 49.35 PAT before Minority Interest 148.67 154.91 117.52 110.05 110.59 106.24 72.62 75.15 47.47 41.11 49.35 Minority Interest 0.72 1.59 2.76 2.38 3.12 3.60 1.07 0.52 -0.12 0.12 0.00 PAT Margin 16.42% 17.24% 16.40% 14.25% 14.59% 15.33% 12.01% 13.24% 12.75% 12.96% 17.00% PAT Growth -4.18% 30.11% 6.98% -1.13% 3.52% 49.06% -2.62% 59.81% 14.84% -16.45% EPS 18.15 19.20 14.76 13.80 13.95 13.48 9.04 9.28 5.81 5.06 6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,453.42 1,281.55 1,156.98 1,029.62 664.59 563.10 412.56 330.79 287.30 235.21 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,445.27 1,273.39 1,148.83 1,021.60 656.88 555.39 405.21 325.88 282.39 226.03 Non-Current Liabilities 208.00 157.15 139.08 241.14 59.29 59.43 65.23 64.16 24.94 27.02 Secured Loans 164.48 80.39 67.08 141.18 0.00 16.23 37.38 43.22 5.07 11.16 Unsecured Loans 0.00 0.70 1.03 1.30 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.72 5.36 5.08 5.55 4.32 3.89 0.88 0.31 0.76 0.60 Current Liabilities 359.86 229.59 251.05 219.71 205.32 160.13 149.05 111.97 109.74 68.37 Trade Payables 76.63 71.37 98.86 103.91 98.20 65.58 86.61 47.74 53.13 24.00 Other Current Liabilities 119.85 76.53 56.68 25.20 25.74 38.28 35.64 21.51 18.28 14.27 Short Term Borrowings 156.40 78.72 92.95 88.04 69.59 50.84 22.02 38.92 35.73 27.86 Short Term Provisions 6.97 2.97 2.57 2.55 11.79 5.43 4.78 3.80 2.60 2.24 Total Liabilities 2,021.28 1,668.29 1,547.11 1,490.47 929.20 782.66 626.84 506.92 421.98 330.60 Net Block 517.00 510.84 488.69 448.85 349.77 280.01 257.66 152.56 140.84 127.09 Gross Block 756.00 723.32 666.58 594.31 469.21 378.74 338.75 212.70 188.18 163.00 Accumulated Depreciation 238.99 212.49 177.89 145.46 119.44 98.73 81.09 60.14 47.34 35.90 Non Current Assets 1,113.59 1,147.87 893.90 786.14 597.17 497.66 402.49 324.23 246.74 159.19 Capital Work in Progress 372.81 401.21 200.99 136.51 89.38 87.71 49.24 114.27 55.27 1.25 Non Current Investment 93.48 89.04 111.35 101.78 94.05 74.24 65.07 37.01 33.11 28.08 Long Term Loans & Adv. 124.54 119.95 68.04 94.26 58.65 55.60 30.48 19.99 17.18 2.46 Other Non Current Assets 5.76 26.83 24.83 4.75 5.31 0.08 0.05 0.40 0.34 0.30 Current Assets 907.69 520.42 653.22 704.32 332.03 284.99 224.36 182.69 175.24 171.41 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 206.23 176.70 167.72 174.96 124.66 120.88 108.95 66.13 59.87 37.44 Sundry Debtors 226.54 181.68 218.14 166.50 111.98 70.12 60.31 31.88 33.19 33.63 Cash & Bank 28.19 90.93 73.14 93.10 5.66 2.49 0.81 10.53 1.95 83.75 Other Current Assets 446.73 55.40 28.59 23.24 30.11 26.15 44.15 23.87 12.22 16.59 Short Term Loans & Adv. 30.17 15.70 46.09 21.91 15.56 4.95 26.77 12.66 5.71 10.51 Net Current Assets 547.83 290.83 402.16 484.62 126.71 124.87 75.31 70.72 65.50 103.04 Total Assets 2,021.28 1,668.29 1,547.12 1,490.46 929.20 782.65 626.85 506.92 421.98 330.60

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,329.36 1,197.58 1,085.03 986.90 639.26 546.94 396.45 320.42 275.98 224.68 Share Capital 8.15 8.15 8.15 8.01 7.71 7.71 7.36 4.90 4.90 4.80 Total Reserves 1,321.21 1,189.43 1,076.88 978.88 631.55 539.23 389.09 315.52 271.07 213.85 Non-Current Liabilities 256.94 166.62 153.48 251.26 67.23 154.15 104.53 98.51 31.13 31.85 Secured Loans 164.48 80.39 67.09 141.20 0.03 71.03 37.43 70.47 5.07 11.42 Unsecured Loans 0.53 0.70 1.03 1.30 0.00 31.30 30.05 0.00 0.00 0.00 Long Term Provisions 26.17 21.77 20.32 16.89 13.96 11.75 9.93 6.92 6.34 5.71 Current Liabilities 407.74 253.44 265.84 236.90 222.07 189.06 166.84 123.77 121.14 80.21 Trade Payables 89.46 80.72 103.74 111.86 106.48 75.50 92.98 51.26 56.72 27.90 Other Current Liabilities 142.11 81.62 59.59 28.03 36.49 49.32 38.23 23.38 20.34 16.65 Short Term Borrowings 165.27 86.58 98.12 92.41 74.10 58.47 30.27 45.07 41.24 33.15 Short Term Provisions 10.90 4.52 4.39 4.60 5.00 5.77 5.37 4.06 2.83 2.51 Total Liabilities 1,986.13 1,610.02 1,499.13 1,472.22 930.89 904.54 677.83 551.42 433.11 338.21 Net Block 650.44 558.01 534.20 491.93 393.41 316.06 294.42 180.67 166.61 146.25 Gross Block 986.42 853.16 793.24 704.89 582.20 476.34 448.38 300.89 271.30 232.84 Accumulated Depreciation 335.98 295.15 259.04 212.96 188.79 160.28 153.96 120.22 104.70 86.59 Non Current Assets 1,365.35 1,064.96 827.16 742.33 576.68 576.77 443.89 339.18 244.95 159.79 Capital Work in Progress 666.25 429.12 209.85 140.51 91.90 221.62 111.03 129.15 57.71 2.72 Non Current Investment 10.45 2.25 20.79 27.99 34.15 0.19 0.21 0.14 0.11 3.65 Long Term Loans & Adv. 32.42 48.75 37.47 77.09 51.86 38.74 38.18 28.82 20.17 6.62 Other Non Current Assets 5.78 26.84 24.86 4.80 5.36 0.16 0.06 0.40 0.34 0.00 Current Assets 620.78 545.06 671.97 729.88 354.21 327.61 233.74 211.99 187.87 178.39 Current Investments 0.00 0.00 119.54 224.62 59.63 65.35 10.14 50.28 68.02 0.00 Inventories 226.43 187.67 188.71 190.00 134.23 130.78 123.25 74.33 67.32 43.33 Sundry Debtors 243.72 203.73 220.27 170.93 125.43 81.37 67.96 41.79 40.53 40.13 Cash & Bank 44.56 94.54 73.83 100.39 11.03 18.42 9.19 16.87 2.27 87.20 Other Current Assets 106.06 45.04 26.08 22.00 23.90 31.69 23.20 28.72 9.72 7.72 Short Term Loans & Adv. 29.25 14.08 43.54 21.95 8.90 4.91 3.23 2.86 3.01 1.56 Net Current Assets 213.04 291.62 406.13 492.98 132.14 138.55 66.90 88.22 66.73 98.18 Total Assets 1,986.13 1,610.02 1,499.13 1,472.21 930.89 904.54 677.83 551.42 433.10 338.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 129.79 164.16 54.46 50.49 119.65 67.35 58.99 35.95 49.57 32.44 PBT 233.99 155.60 167.49 168.53 148.70 118.93 102.08 55.61 51.29 65.84 Adjustment -5.39 25.78 8.68 15.28 18.05 22.61 16.42 8.34 7.28 6.66 Changes in Working Capital -57.95 18.23 -81.25 -99.93 -15.54 -49.19 -38.22 -17.11 -1.22 -27.41 Cash after chg. in Working capital 170.65 199.61 94.92 83.89 151.21 92.35 80.29 46.84 57.35 45.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -40.85 -35.45 -40.45 -33.40 -31.55 -25.01 -21.30 -10.89 -7.78 -12.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -295.08 -214.71 -12.83 -274.78 -100.98 -139.48 -38.20 -63.04 -144.57 -9.02 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -286.36 -99.60 28.41 70.17 5.25 3.36 10.74 6.64 7.68 20.60 Cash from Financing Activity 170.10 8.17 -61.16 315.27 -14.58 73.82 -30.51 35.67 12.99 58.24 Net Cash Inflow / Outflow 4.82 -42.38 -19.53 90.98 4.09 1.69 -9.72 8.58 -82.01 81.66 Opening Cash & Equivalents 30.76 73.14 92.68 1.70 -3.02 0.81 10.53 1.95 83.96 2.09 Closing Cash & Equivalent 28.19 30.76 73.14 92.68 1.07 2.49 0.81 10.53 1.95 83.75

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 123.72 146.78 44.92 37.48 128.70 68.81 70.04 43.64 56.73 40.86 PBT 188.40 143.70 136.77 146.49 140.36 107.84 95.45 57.00 53.51 64.13 Adjustment 41.32 20.44 18.83 17.19 20.61 26.46 19.62 11.52 10.19 10.42 Changes in Working Capital -63.80 18.71 -69.66 -92.61 -2.70 -40.11 -23.44 -13.90 0.77 -21.04 Cash after chg. in Working capital 165.92 182.85 85.94 71.08 158.27 94.19 91.62 54.62 64.46 53.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.20 -36.07 -41.02 -33.60 -29.56 -25.38 -21.58 -10.98 -7.73 -12.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -288.85 -196.16 -8.76 -262.23 -109.20 -195.18 -48.93 -95.21 -152.31 7.77 Net Fixed Assets -4.28 -256.96 -136.75 -172.23 -92.14 -78.46 -61.02 -83.52 -79.20 -5.23 Net Investments -4.44 141.85 95.51 -172.72 -14.09 -64.38 12.08 13.84 -73.05 -24.39 Others -280.13 -81.05 32.48 82.72 -2.97 -52.34 0.01 -25.53 -0.06 37.39 Cash from Financing Activity 175.50 10.06 -60.91 312.70 -19.65 135.05 -28.34 66.31 10.02 35.93 Net Cash Inflow / Outflow 10.38 -39.32 -24.75 87.95 -0.15 8.68 -7.23 14.74 -85.56 84.56 Opening Cash & Equivalents 34.36 73.83 99.97 7.05 3.61 9.19 16.87 2.27 87.83 2.65 Closing Cash & Equivalent 44.56 34.36 73.83 99.97 6.43 18.42 9.19 16.87 2.27 87.20

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 178.28 157.19 141.91 128.50 86.20 73.03 112.15 89.92 78.10 64.06 ROA 10.50% 7.72% 8.77% 10.53% 13.19% 11.93% 14.26% 9.90% 10.56% 17.77% ROE 14.17% 10.18% 12.19% 15.05% 18.39% 17.24% 21.75% 14.87% 15.34% 29.67% ROCE 14.44% 11.27% 13.00% 16.98% 21.70% 21.49% 22.89% 14.93% 16.97% 29.19% Fixed Asset Turnover 1.09 0.96 1.18 1.39 1.61 1.59 1.94 1.67 1.62 1.65 Receivable days 92.44 109.91 94.36 68.87 48.77 41.69 31.48 35.42 42.78 45.13 Inventory Days 86.71 94.68 84.06 74.10 65.76 73.47 59.79 68.58 62.31 56.19 Payable days 46.77 62.82 63.90 61.73 57.90 62.98 59.11 68.15 62.12 57.27 Cash Conversion Cycle 132.38 141.78 114.52 81.24 56.63 52.19 32.17 35.85 42.98 44.05 Total Debt/Equity 0.26 0.15 0.16 0.23 0.13 0.15 0.19 0.30 0.19 0.22 Interest Cover 55.05 56.69 79.92 61.31 46.45 31.65 31.05 29.59 27.03 29.94

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 163.06 146.89 133.09 123.17 82.91 70.92 107.72 43.52 74.94 60.67 ROA 8.62% 7.56% 7.41% 9.20% 11.58% 9.18% 12.23% 9.64% 10.66% 16.84% ROE 12.26% 10.30% 10.62% 13.60% 17.92% 15.40% 20.98% 15.93% 16.63% 30.96% ROCE 12.41% 11.05% 11.71% 15.91% 19.90% 17.90% 20.48% 15.04% 18.02% 28.98% Fixed Asset Turnover 0.99 0.89 1.06 1.22 1.36 1.34 1.54 1.32 1.28 1.30 Receivable days 89.94 105.51 90.20 69.00 52.26 43.99 34.62 39.70 45.47 46.24 Inventory Days 83.24 93.66 87.32 75.49 66.97 74.84 62.33 68.31 62.38 57.79 Payable days 46.83 58.00 61.51 60.89 60.10 62.86 57.06 63.94 59.10 55.44 Cash Conversion Cycle 126.35 141.17 116.00 83.61 59.13 55.97 39.90 44.07 48.76 48.59 Total Debt/Equity 0.29 0.16 0.18 0.24 0.14 0.34 0.30 0.41 0.22 0.26 Interest Cover 42.34 40.09 55.10 49.69 37.07 27.63 28.09 26.13 24.13 25.28

Top Investors:

ta fii investors fund

tano mauritius india fvci ii

pivotal enterprises private limited

pivotal business managers llp

duro one investments limited

nippon life india trustee ltd-a/c nippon india small cap fund

india opportunities growth fund ltd - pinewood str

qib

iepf

Annual Reports:

News Update:

Shilpa Medicare gets nod to transfer API Business to WOS
13th Jul 2021, 11:29 AM

The company has received approval from Board of Directors for transfer of API Business of the Company consisting of Unit-1 and Unit-2 situated at Raichur, Karnataka
Read More
Shilpa Medicare gets approval to manufacture, sale of 2-Deoxy-D-Glucose
25th Jun 2021, 11:14 AM

2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients
Read More
Shilpa Medicare launches pediatric dose Paracetamol Oral Thin Film
22nd Jun 2021, 10:59 AM

The company received approval for Molshil Oral Thin Films after sufficiently complying bioequivalence requirements
Read More
Shilpa Medicare’s finished dosage formulation facility gets GMP certification from Russian Federation
28th May 2021, 16:29 PM

There were No Critical, Major and Minor observations found during GMP inspection process
Read More
Shilpa Medicare’s arm ties up with Dr. Reddy's for production of Sputnik V vaccine
17th May 2021, 10:16 AM

DRL has partnered with HVIRDIF for clinical development of the vaccine and has distribution rights in geographies including India
Read More
Shilpa Medicare’s US operating company sues Novartis Pharmaceutical Corporation
27th Apr 2021, 09:12 AM

The company is seeking relief for the infringement of the US Patent entitled ‘Fingolimod Polymorph and Their Processes’
Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: